Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Shares Issued (2018 - 2025)

Organogenesis Holdings (ORGO) has 7 years of Shares Issued data on record, last reported at $2000.0 in Q4 2025.

  • For Q4 2025, Shares Issued fell 99.81% year-over-year to $2000.0; the TTM value through Dec 2025 reached $157000.0, down 87.41%, while the annual FY2025 figure was $157000.0, 87.41% down from the prior year.
  • Shares Issued reached $2000.0 in Q4 2025 per ORGO's latest filing, down from $130000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $1.8 million in Q2 2022 and bottomed at $2000.0 in Q4 2025.
  • Average Shares Issued over 4 years is $436307.7, with a median of $180000.0 recorded in 2024.
  • Peak YoY movement for Shares Issued: plummeted 99.87% in 2021, then surged 3150.0% in 2025.
  • A 4-year view of Shares Issued shows it stood at $83000.0 in 2021, then tumbled by 66.27% to $28000.0 in 2022, then soared by 3696.43% to $1.1 million in 2024, then tumbled by 99.81% to $2000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $2000.0 in Q4 2025, $130000.0 in Q3 2025, and $25000.0 in Q1 2025.